Page last updated: 2024-11-03

riluzole and Astrocytoma, Grade IV

riluzole has been researched along with Astrocytoma, Grade IV in 5 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research Excerpts

ExcerptRelevanceReference
"The riluzole treatment of all GBM cell lines mainly affected carbohydrate metabolism and the DNA structure."5.72Live-Cell Synchrotron-Based FTIR Evaluation of Metabolic Compounds in Brain Glioblastoma Cell Lines after Riluzole Treatment. ( Birarda, G; Dimitrijević, D; Dučić, T; Jover Mañas, GV; Martínez-Rovira, I; Ninkovic, M; Rohde, V; Sperling, S; Vaccari, L; Yousef, I, 2022)
"The riluzole treatment of all GBM cell lines mainly affected carbohydrate metabolism and the DNA structure."1.72Live-Cell Synchrotron-Based FTIR Evaluation of Metabolic Compounds in Brain Glioblastoma Cell Lines after Riluzole Treatment. ( Birarda, G; Dimitrijević, D; Dučić, T; Jover Mañas, GV; Martínez-Rovira, I; Ninkovic, M; Rohde, V; Sperling, S; Vaccari, L; Yousef, I, 2022)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Dučić, T1
Ninkovic, M2
Martínez-Rovira, I1
Sperling, S2
Rohde, V2
Dimitrijević, D1
Jover Mañas, GV1
Vaccari, L1
Birarda, G1
Yousef, I1
Benavides-Serrato, A1
Saunders, JT1
Holmes, B1
Nishimura, RN1
Lichtenstein, A1
Gera, J1
Yamada, T1
Tsuji, S1
Nakamura, S1
Egashira, Y1
Shimazawa, M1
Nakayama, N1
Yano, H1
Iwama, T1
Hara, H1
Sachkova, A1
Mielke, D1
Schatlo, B1
Yelskaya, Z1
Carrillo, V1
Dubisz, E1
Gulzar, H1
Morgan, D1
Mahajan, SS1

Other Studies

5 other studies available for riluzole and Astrocytoma, Grade IV

ArticleYear
Live-Cell Synchrotron-Based FTIR Evaluation of Metabolic Compounds in Brain Glioblastoma Cell Lines after Riluzole Treatment.
    Analytical chemistry, 2022, 02-01, Volume: 94, Issue:4

    Topics: Brain; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Riluzole; Spectroscopy, Fourier Tran

2022
Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma.
    International journal of molecular sciences, 2020, Jan-05, Volume: 21, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug

2020
Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma.
    Journal of neurosurgery, 2020, Mar-13, Volume: 134, Issue:3

    Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Ne

2020
Combined Applications of Repurposed Drugs and Their Detrimental Effects on Glioblastoma Cells.
    Anticancer research, 2019, Volume: 39, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cel

2019
Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.
    PloS one, 2013, Volume: 8, Issue:5

    Topics: Amino Acids; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation;

2013